{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:26:47Z","timestamp":1774466807015,"version":"3.50.1"},"reference-count":3,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Teriparatide, an osteoanabolic agent, is a biosynthetic analogue of the 1-34 amino acids of human parathyroid hormone (PTH) used for the treatment of osteoporosis. It is typically well-tolerated; common side effects include headaches, arthralgias, nausea, and dizziness. In this report, we present a case of gynecomastia occurring shortly after initiating teriparatide therapy, associated with nipple sensitivity and breast tenderness. Secondary workup for various causes of gynecomastia was unremarkable. Finally, a decision was made to discontinue teriparatide due to the patient\u2019s concerns. The nipple sensitivity started improving shortly afterward, with complete resolution of gynecomastia 4 months later. Although this unusual side effect has been reported as a possibility in postmarketing studies, a chronological report on the occurrence of teriparatide-induced gynecomastia and its complete resolution after discontinuing teriparatide has not yet been published in the literature.<\/jats:p>","DOI":"10.1210\/jcemcr\/luae098","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T16:31:36Z","timestamp":1719419496000},"source":"Crossref","is-referenced-by-count":1,"title":["Looking Beyond the Usual Suspects: A Rare Case of Teriparatide-Induced Gynecomastia"],"prefix":"10.1210","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0374-5839","authenticated-orcid":false,"given":"Bhanvi","family":"Ramchandani","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, UConn Health , Farmington, CT 06030 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7331-097X","authenticated-orcid":false,"given":"Faryal Sardar","family":"Mirza","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, UConn Health , Farmington, CT 06030 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"issue":"18","key":"2024062616312907200_luae098-B1","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.2165\/0003495-200868180-00012","article-title":"Teriparatide: a review of its use in osteoporosis","volume":"68","author":"Blick","year":"2008","journal-title":"Drugs"},{"issue":"6","key":"2024062616312907200_luae098-B2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1742-7843.2004.pto940602.x","article-title":"Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis","volume":"94","author":"Brixen","year":"2004","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"2024062616312907200_luae098-B3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10911-013-9283-7","article-title":"Parathyroid hormone-related protein specifies the mammary mesenchyme and regulates embryonic mammary development","volume":"18","author":"Hiremath","year":"2013","journal-title":"J Mammary Gland Biol Neoplasia"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/2\/6\/luae098\/58340772\/luae098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/2\/6\/luae098\/58340772\/luae098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T16:31:40Z","timestamp":1719419500000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luae098\/7699715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":3,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,5,24]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luae098","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,5,24]]},"article-number":"luae098"}}